Clinical Trial Update: Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing trimethoprim-sulfamethoxazole plus rifampicin to linezolid for MRSA infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Linezolid (Linezolid)
• Rifampicin
• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University Hospital, Geneva | Conditions: MRSA Infection | Phase 4 | Status: COMPLETED